Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127436131 | 12743613 | 1 | I | 20150601 | 20160914 | 20160914 | PER | PHHY2015US068383 | SANDOZ | 0.00 | M | Y | 0.00000 | 20160914 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127436131 | 12743613 | 1 | SS | LUCENTIS | RANIBIZUMAB | 1 | Intraocular | 0.3 MG, QMO | U | 0 | .3 | MG | INJECTION | /month | |||||
| 127436131 | 12743613 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | U | 0 | INJECTION | ||||||||||
| 127436131 | 12743613 | 3 | PS | NAPROXEN. | NAPROXEN | 1 | Unknown | U | 74140 | ||||||||||
| 127436131 | 12743613 | 4 | C | EFFIENT | PRASUGREL HYDROCHLORIDE | 1 | Unknown | 10 MG, UNK | U | 0 | 10 | MG | |||||||
| 127436131 | 12743613 | 5 | C | EFFIENT | PRASUGREL HYDROCHLORIDE | 1 | Unknown | U | 0 | 10 | MG | ||||||||
| 127436131 | 12743613 | 6 | C | GLYBURIDE. | GLYBURIDE | 1 | Unknown | U | 0 | ||||||||||
| 127436131 | 12743613 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | U | 0 | ||||||||||
| 127436131 | 12743613 | 8 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 127436131 | 12743613 | 9 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | U | 0 | ||||||||||
| 127436131 | 12743613 | 10 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | U | 0 | ||||||||||
| 127436131 | 12743613 | 11 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127436131 | 12743613 | 1 | Eye swelling |
| 127436131 | 12743613 | 2 | Diabetic retinal oedema |
| 127436131 | 12743613 | 3 | Product used for unknown indication |
| 127436131 | 12743613 | 4 | Product used for unknown indication |
| 127436131 | 12743613 | 6 | Diabetes mellitus |
| 127436131 | 12743613 | 7 | Blood pressure abnormal |
| 127436131 | 12743613 | 8 | Product used for unknown indication |
| 127436131 | 12743613 | 9 | Blood pressure abnormal |
| 127436131 | 12743613 | 10 | Product used for unknown indication |
| 127436131 | 12743613 | 11 | Blood cholesterol |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127436131 | 12743613 | Drug hypersensitivity | |
| 127436131 | 12743613 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |